Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Ciprofloxacin Market: By Dosage Form, By Application, By Distribution Channel and Geography
Ciprofloxacin Market Size was valued at US$ x million in 2023 and is poised to grow at a 7.2% CAGR from 2024 to 2030. Ciprofloxacin is one of the broad-spectrum antibiotics for the drug class quinolone antibiotic. To maintain the antibiotic's effectiveness, the antibiotic Ciprofloxacin is largely employed to stop the growth of bacteriophages that are resistant to it. Only bacterial illnesses are treated with the medication ciprofloxacin; viral infections are not affected by it. The Urinary Tract Infections segment anticipated to grow at significant CAGR over the forecast years owing to Due to differences in anatomy, women are more likely than men to get urinary tract infections. In their lifetimes, many women get urinary tract infections more than once. According to some research, there are 150 million cases of urinary tract infections worldwide. Additionally, about 11% of women see a doctor for treatment of a UTI once a year. Moreover, competitors are focusing on launching and acquisition to maintain growth in the market. For instance, In December 2002 FDA Approves Once-Daily Cipro XR for the Treatment of Uncomplicated Urinary Tract Infections (UTIs). Increase in prevalence of bacterial infection such as (UTI), eye infections, among others is anticipated to create lucrative growth opportunities for the ciprofloxacin market.
Study Period
2024-2030Base Year
2023CAGR
7.2%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The incidence of kidney infections and eye infections is one of the main factors propelling the Ciprofloxacin market's expansion. due to higher efficacy of Ciprofloxacin in treating the infections associated with the excretory system especially renal and urinary system. In June 2018 the US FDA warned the manufacturers and issued guidelines for the labeling black box warning mentioning safety warnings for the fluoroquinolones category of medicines. Considering the drug's negative effects on tendons and skin in paediatric and geriatric patients. It is projected that there would be a significant increase in demand for ciprofloxacin because of the requirement for broad spectrum antibiotics in the global pharmaceutical market.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market CAGR |
7.2% |
By Dosage Form |
|
By Application |
|
By Distribution Channel |
|
By Region |
|
Download Free Sample Report
The Ciprofloxacin Market size was valued at US$ x million in 2023
The ciprofloxacin market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The ciprofloxacin market key players are Novartis International AG, Allergan plc, Merck & Co Inc, Cipla Limited, Bayer AG, Cadila Healthcare, Glenmark Pharmaceuticals, Hexal, Sanofi Synthelabo, Pfleger, Mylan Laboratories Ltd
1.Executive Summary |
2.Global Ciprofloxacin Market Introduction |
2.1.Global Ciprofloxacin Market - Taxonomy |
2.2.Global Ciprofloxacin Market - Definitions |
2.2.1.Dosage Form |
2.2.2.Application |
2.2.3.Distribution Channel |
2.2.4.Region |
3.Global Ciprofloxacin Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Ciprofloxacin Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Ciprofloxacin Market By Dosage Form, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Powder |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Suspension |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Tablet |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Eye drops |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Intravenous preparation |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6.Global Ciprofloxacin Market By Application , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Urinary Tract Infections |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Lower Respiratory Infections |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Nosocomial Pneumonia |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Skin Structure Infections |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Bone and Joint Infections |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Intra-Abdominal Infection |
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Acute Sinusitis |
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
6.8. Chronic Bacterial Prostatitis |
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.8.3. Market Opportunity Analysis |
7.Global Ciprofloxacin Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals Pharmacies |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Retail pharmacies |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Drug stores |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Online pharmacies |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Ciprofloxacin Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Ciprofloxacin Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Dosage Form Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Powder |
9.1.2.Suspension |
9.1.3.Tablet |
9.1.4.Eye drops |
9.1.5.Intravenous preparation |
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Urinary Tract Infections |
9.2.2.Lower Respiratory Infections |
9.2.3.Nosocomial Pneumonia |
9.2.4.Skin Structure Infections |
9.2.5.Bone and Joint Infections |
9.2.6.Intra-Abdominal Infection |
9.2.7.Acute Sinusitis |
9.2.8.Chronic Bacterial Prostatitis |
9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals Pharmacies |
9.3.2.Retail pharmacies |
9.3.3.Drug stores |
9.3.4.Online pharmacies |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Ciprofloxacin Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Dosage Form Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Powder |
10.1.2.Suspension |
10.1.3.Tablet |
10.1.4.Eye drops |
10.1.5.Intravenous preparation |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Urinary Tract Infections |
10.2.2.Lower Respiratory Infections |
10.2.3.Nosocomial Pneumonia |
10.2.4.Skin Structure Infections |
10.2.5.Bone and Joint Infections |
10.2.6.Intra-Abdominal Infection |
10.2.7.Acute Sinusitis |
10.2.8.Chronic Bacterial Prostatitis |
10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals Pharmacies |
10.3.2.Retail pharmacies |
10.3.3.Drug stores |
10.3.4.Online pharmacies |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11.Asia Pacific (APAC) Ciprofloxacin Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Dosage Form Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Powder |
11.1.2.Suspension |
11.1.3.Tablet |
11.1.4.Eye drops |
11.1.5.Intravenous preparation |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Urinary Tract Infections |
11.2.2.Lower Respiratory Infections |
11.2.3.Nosocomial Pneumonia |
11.2.4.Skin Structure Infections |
11.2.5.Bone and Joint Infections |
11.2.6.Intra-Abdominal Infection |
11.2.7.Acute Sinusitis |
11.2.8.Chronic Bacterial Prostatitis |
11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals Pharmacies |
11.3.2.Retail pharmacies |
11.3.3.Drug stores |
11.3.4.Online pharmacies |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Ciprofloxacin Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Dosage Form Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Powder |
12.1.2.Suspension |
12.1.3.Tablet |
12.1.4.Eye drops |
12.1.5.Intravenous preparation |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Urinary Tract Infections |
12.2.2.Lower Respiratory Infections |
12.2.3.Nosocomial Pneumonia |
12.2.4.Skin Structure Infections |
12.2.5.Bone and Joint Infections |
12.2.6.Intra-Abdominal Infection |
12.2.7.Acute Sinusitis |
12.2.8.Chronic Bacterial Prostatitis |
12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals Pharmacies |
12.3.2.Retail pharmacies |
12.3.3.Drug stores |
12.3.4.Online pharmacies |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Ciprofloxacin Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Dosage Form Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Powder |
13.1.2.Suspension |
13.1.3.Tablet |
13.1.4.Eye drops |
13.1.5.Intravenous preparation |
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Urinary Tract Infections |
13.2.2.Lower Respiratory Infections |
13.2.3.Nosocomial Pneumonia |
13.2.4.Skin Structure Infections |
13.2.5.Bone and Joint Infections |
13.2.6.Intra-Abdominal Infection |
13.2.7.Acute Sinusitis |
13.2.8.Chronic Bacterial Prostatitis |
13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals Pharmacies |
13.3.2.Retail pharmacies |
13.3.3.Drug stores |
13.3.4.Online pharmacies |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Novartis International AG |
14.2.2.Allergan plc |
14.2.3.Merck & Co Inc |
14.2.4.Cipla Limited |
14.2.5.Bayer AG |
14.2.6.Cadila Healthcare |
14.2.7.Glenmark Pharmaceuticals |
14.2.8.Hexal |
14.2.9.Sanofi Synthelabo |
14.2.10.Pfleger |
14.2.11.Mylan Laboratories Ltd |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players